AI Generated Image
Decades of research on bacterial diarrhea yields new vaccine technology
Fox News • • health
Key Points:
- Researchers have developed a new technology targeting enterotoxigenic Escherichia coli (ETEC), a leading cause of severe diarrheal illness, and licensed it to French vaccine manufacturer Valneva for further development.
- ETEC disproportionately affects children in low- and middle-income countries, and despite decades of research, no broadly effective vaccine currently exists.
- The new approach focuses on an ETEC toxin that has been a major obstacle in vaccine development, showing promising antibody responses that may protect against diarrheal illness.
- Experts caution that while the findings are encouraging, significant work remains, including additional studies, clinical trials, and regulatory approvals before the vaccine can be made available.
- In the meantime, travelers are advised to take precautions such as avoiding high-risk foods, drinking bottled water, practicing good hygiene, and consulting physicians about existing vaccines like those for typhoid fever.
